Clinical Trial

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 4, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Protocol Amendment History 29 amendments
This ClinicalTrials.gov record has been amended 29 times since 2021-07-08; most recent amendment 2025-11-01.
Status change: Recruiting → Active, Not Recruiting 2025-11-01
Status change: Not Yet Recruiting → Recruiting 2021-09-13
Trial Details
NCT Number NCT04968548
Lead Sponsor Nucleix Ltd.
Conditions Lung Cancer
Enrollment 5,000 participants
Start Date 2021-09-17
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-04